×

NOVARTIS SETS U.S. PRICE OF $475,000 FOR KYMRIAH GENE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA

NOVARTIS SETS U.S. PRICE OF $475,000 FOR KYMRIAH GENE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA